News
The TRIOMPHE study is a prospective, multicenter, three-arm trial designed to assess the safety and effectiveness of the NEXUS Aortic Arch Stent-Graft System in patients with aortic arch ...
The TRIOMPHE study is a prospective, multicenter, three-arm trial designed to assess the safety and effectiveness of the NEXUS Aortic Arch Stent-Graft System in patients with aortic arch ...
King Salman Park is set to become one of the world's largest urban green spaces, transforming the site of Saudi Arabia's former military airport into a cultural and recreational hub. Covering 16 ...
The Nexus aortic arch stent graft system. [Image from Endospan] Endospan today announced the presentation of 30-day results from a study evaluating its Nexus aortic arch stent graft system.
May 5, 2025—Endospan announced 30-day results of the statistical Dissection primary arm from the TRIOMPHE investigational device exemption (IDE) clinical study, which is evaluating the company’s Nexus ...
TEL AVIV, Israel--(BUSINESS WIRE)-- Endospan today announced the presentation of 30-day results of the statistical Dissection Primary Arm from the TRIOMPHE Investigational Device Exemption (IDE) ...
This program began in spring 2019, as part of a federal and state effort to do more to track ticks and tick-borne diseases. The goal is to figure out where tick populations are being established, how ...
Jamie L Cantoni, agricultural research technician and field technician, drags along a white cloth to catch ticks in Lyme, Connecticut, on April 16, 2025. In 1975, a cluster of children in Lyme ...
Objectives The use of cerebral embolic protection (CEP) during transcatheter aortic valve implantation (TAVI ... of the limitations inherent to current systems, such as incomplete arch vessel coverage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results